..
In Malaysia, among 396,392 #COVID19 confirmed cases during Omicron (BA4/BA5) proxy period Jul-Dec 2022, Case fatality rate (CFR) for unvaccinated was 1.43% compared to fully vaccinated (0.54%). Those received a 2nd booster dose had the lowest #CFR (0.10%). @ICR_NIH @KKMPutrajaya
— Dr Kalai Peariasamy (@drkalai61) January 6, 2023
..
Di 🇲🇾, antara 396,392 jangkitan #COVID19 dalam tempoh proksi Omicron (BA4/BA5) Jul-Dis 2022, Kadar kematian kes (CFR) bagi yang tidak divaksin ialah 1.43% berbanding divaksin sepenuhnya (0.54%). Penerima dos penggalak kedua mempunyai #CFR terendah (0.10%) @ICR_NIH @KKMPutrajaya
— Dr Kalai Peariasamy (@drkalai61) January 6, 2023
..
An important study from 🇲🇾 that reaffirmed ivermectin did not prevent progression to severe disease when used in high-risk patients with #COVID19. An excellent example of teamwork and clinical trial capacity locally led by @stevenlimcl @drkalai61 @NIHMalaysia et al. #ITECH https://t.co/JxaudvAZre
— Giri Rajahram (@GSRajahram) December 23, 2022
..
Updated ICR modelling study 14 Dec 2022 estimated #COVID19 vaccines averted 38200 deaths in Malaysia. @ICR_NIH @KKMPutrajaya pic.twitter.com/j7YHP6WXJU
— Dr Kalai Peariasamy (@drkalai61) December 14, 2022
..
..
Ivermectin not effective for Covid-19 progression: I-TECH clinical trial results (Malaysia)
..
Ivermectin randomised trial of 500 high-risk patients in Malaysia: Negative results
..
Malaysia has completed its Ivermectin study: Not recommended as treatment for Covid-19
..
Reactions to Malaysia’s Ivermectin research: Ivermectin proponents are not happy, to put it mildly
..
weehingthong